2V
Verastem, Inc.
2VSA.F · FSX
6.44 € +0.59% (+0.04 €)
1M +8.60%
Market Cap $645.5M
P/E Ratio -
Div. Yield -
ROE 468.00%
Piotroski F-Score Moderate
4/9Valuation
6 /100
Expensive P/S 7.38x
P/B 12.91x
P/E N/A
Growth
91 /100
Growing Rev. growth 128.36%
Book val. growth 6.47%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 86.69%
FCF margin 185.24%
Net margin 231.61%
Quality
5 /100
Poor ROIC 119.33%
Asset turnover 0.42x
ROE 468.00%
Debt
36 /100
Moderate Debt/Equity 1.69x
Int. coverage -147.99x
Current ratio 2.25x
Stability
38 /100
Moderate Beta 0.29x
Profitable years 0
EPS volatility 30.48%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o 2VSA.F
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Daniel W. Paterson
Employees
102
Headquarters
Needham
Nadchodzące wydarzenia
03 LIS
Earnings
Upcoming earnings report